title: [Morbihan disease as a special form of rosacea: review of pathogenesis and new therapeutic options].
abstract: Morbihan disease is classified as a special form of rosacea, which presents with persistent facial erythema and solid edema because of marked involvement of the lymphatic vessels. The cheeks, nose and forehead are particularly affected. Currently, the treatment options of this cosmetically very disturbing disease are limited. However, every attempt should be made to provide treatment because of the great emotional suffering of the patients. We review some new currently available therapeutic options for Morbihan disease. In our patient, we were able to achieve a significant improvement with systemic isotretinoin 30 mg/day over a period of 12 months.
authors.affiliation: Klinik für Dermatologie und Allergologie, Universitätsklinikum der RWTH Aachen, Pauwelsstr. 30, 52074, Aachen, Deutschland, gbalakirski@ukaachen.de.
authors.forename: G
authors.initials: G
authors.lastname: Balakirski
authors.forename: J M
authors.initials: JM
authors.lastname: Baron
authors.forename: M
authors.initials: M
authors.lastname: Megahed
mesh_terms: D003879:Dermatologic Agents / Q000627:therapeutic use; D004890:Erythema / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D005148:Facial Dermatoses / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D005260:Female; D006801:Humans; D015474:Isotretinoin / Q000627:therapeutic use*; D008875:Middle Aged; D012393:Rosacea / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D003879:Dermatologic Agents; D015474:Isotretinoin